Developing a Clinical Research Agenda for Fecal Incontinence

(Download includes CME accreditation material)

Topic Information

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists, colorectal surgeons, urogynecologists, physician assistants, and nurse practitioners involved in the care of patients with fecal incontinence.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the epidemiology and burden of illness and pathophysiology of fecal incontinence

Describe the current and future management of fecal incontinence

Formulate an appropriate treatment plan for fecal incontinence, taking into account clinical presentation and patient preference

Credit Designation

Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this enduring material is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

Release Date: March 10, 2014Expiration Date: March 10, 2015  EXPIRED

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education (ACHS), consults for Pfizer, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and The Gi Health Foundation has no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty: Satish S. Rao, MBBS, Director Digestive Health Center,
Section Chief of Gastroenterology/Hepatology,
Professor of Medicine, Georgia Regents University, Augusta, GA

Physician Disclosure Statement

Satish Rao, MD, has served as a consultant and as an advisory board member for SmartPill Corporation, American Medical Systems, Inc., AstraZeneca, Ironwood Pharmaceuticals, Inc., and Asubio Pharmaceuticals, Inc. Dr. Rao has received research grants from SmartPill Corporation and Forest Laboratories, Inc.


© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.